pubmed-article:9366536 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C1318309 | lld:lifeskim |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C1417725 | lld:lifeskim |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C0439148 | lld:lifeskim |
pubmed-article:9366536 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:9366536 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:9366536 | pubmed:dateCreated | 1997-11-25 | lld:pubmed |
pubmed-article:9366536 | pubmed:abstractText | We recently changed from using fine needle aspiration cytology to using core biopsy exclusively in the assessment of screen detected abnormalities. Two hundred and two biopsies (1% of women screened) were performed. Surgical histological confirmation was obtained in 111 patients (101 malignant and 10 benign). The remaining patients were either returned to standard 3-yearly screening or early repeat screening after 1 year. Analysis of the results was performed in accordance with the standards specified in the National Health Service Breast Screening Programme (NHSBSP) Publication Number 22. Absolute sensitivity was 89.3%, complete sensitivity was 93.2%, specificity (including patients undergoing both surgical excision and follow-up) was 88.7%. The predictive value of a positive (malignant) core biopsy result was 100%. The false negative rate was 3.9%. Twelve (5.9%) biopsies were classified inadequate for diagnosis. Core biopsy is a safe and accurate way of assessing screen detected abnormalities and can be used as a substitute for fine needle aspiration cytology with results that exceed the National Health Service Breast Screening Programme target standards, even in the learning phase. | lld:pubmed |
pubmed-article:9366536 | pubmed:language | eng | lld:pubmed |
pubmed-article:9366536 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9366536 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9366536 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9366536 | pubmed:month | Oct | lld:pubmed |
pubmed-article:9366536 | pubmed:issn | 0009-9260 | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:WightD GDG | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:WarrenRR | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:GoddardM JMJ | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:FlowerC DCD | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:FreemanA HAH | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:BobrowLL | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:BrittonP DPD | lld:pubmed |
pubmed-article:9366536 | pubmed:author | pubmed-author:SinnatambyRR | lld:pubmed |
pubmed-article:9366536 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9366536 | pubmed:volume | 52 | lld:pubmed |
pubmed-article:9366536 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9366536 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9366536 | pubmed:pagination | 764-7 | lld:pubmed |
pubmed-article:9366536 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:meshHeading | pubmed-meshheading:9366536-... | lld:pubmed |
pubmed-article:9366536 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9366536 | pubmed:articleTitle | Changing to core biopsy in an NHS breast screening unit. | lld:pubmed |
pubmed-article:9366536 | pubmed:affiliation | Department of Radiology, Addenbrooke's Hospital and Cambridge University, UK. | lld:pubmed |
pubmed-article:9366536 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9366536 | pubmed:publicationType | Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9366536 | lld:pubmed |